| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Linus Pauling Institute, 2 Department of Biochemistry and Biophysics, and 3 Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon; and 4 Institute for Cancer Prevention, American Health Foundation Cancer Center, Valhalla, New York
Sulforaphane (SFN), a compound found at high levels in broccoli and broccoli sprouts, is a potent inducer of phase 2 detoxification enzymes and inhibits tumorigenesis in animal models. SFN also has a marked effect on cell cycle checkpoint controls and cell survival and/or apoptosis in various cancer cells, through mechanisms that are poorly understood. We tested the hypothesis that SFN acts as an inhibitor of histone deacetylase (HDAC). In human embryonic kidney 293 cells, SFN dose-dependently increased the activity of a ß-catenin-responsive reporter (TOPflash), without altering ß-catenin or HDAC protein levels. Cytoplasmic and nuclear extracts from these cells had diminished HDAC activity, and both global and localized histone acetylation was increased, compared with untreated controls. Studies with SFN and with media from SFN-treated cells indicated that the parent compound was not responsible for the inhibition of HDAC, and this was confirmed using an inhibitor of glutathione S-transferase, which blocked the first step in the metabolism of SFN, via the mercapturic acid pathway. Whereas SFN and its glutathione conjugate (SFN-GSH) had little or no effect, the two major metabolites SFN-cysteine and SFN-N-acetylcysteine were effective HDAC inhibitors in vitro. Finally, several of these findings were recapitulated in HCT116 human colorectal cancer cells: SFN dose-dependently increased TOPflash reporter activity and inhibited HDAC activity, there was an increase in acetylated histones and in p21Cip1/Waf1, and chromatin immunoprecipitation assays revealed an increase in acetylated histones bound to the P21 promoter. Collectively, these findings suggest that SFN may be effective as a tumor-suppressing agent and as a chemotherapeutic agent, alone or in combination with other HDAC inhibitors currently undergoing clinical trials.
This article has been cited by other articles:
|
|
 |
|
  A. Gibbs, J. Schwartzman, V. Deng, and J. Alumkal Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6 PNAS, September 29, 2009; 106(39): 16663 - 16668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nian, W. H. Bisson, W.-M. Dashwood, J. T. Pinto, and R. H. Dashwood {alpha}-Keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells Carcinogenesis, August 1, 2009; 30(8): 1416 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-I. Lee, H. Nian, A. J.L. Cooper, R. Sinha, J. Dai, W. H. Bisson, R. H. Dashwood, and J. T. Pinto {alpha}-Keto Acid Metabolites of Naturally Occurring Organoselenium Compounds as Inhibitors of Histone Deacetylase in Human Prostate Cancer Cells Cancer Prevention Research, July 1, 2009; 2(7): 683 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Azarenko, T. Okouneva, K. W. Singletary, M. A. Jordan, and L. Wilson Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane Carcinogenesis, December 1, 2008; 29(12): 2360 - 2368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nian, B. Delage, J. T. Pinto, and R. H. Dashwood Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter Carcinogenesis, September 1, 2008; 29(9): 1816 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mi, Z. Xiao, B. L. Hood, S. Dakshanamurthy, X. Wang, S. Govind, T. P. Conrads, T. D. Veenstra, and F.-L. Chung Covalent Binding to Tubulin by Isothiocyanates: A MECHANISM OF CELL GROWTH ARREST AND APOPTOSIS J. Biol. Chem., August 8, 2008; 283(32): 22136 - 22146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Kopelovich, J. R. Fay, C. C. Sigman, and J. A. Crowell The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1330 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. H. Huh, J.-H. Ryu, and J.-S. Chun Regulation of Type II Collagen Expression by Histone Deacetylase in Articular Chondrocytes J. Biol. Chem., June 8, 2007; 282(23): 17123 - 17131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pledgie-Tracy, M. D. Sobolewski, and N. E. Davidson Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines Mol. Cancer Ther., March 1, 2007; 6(3): 1013 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Myzak, P. Tong, W.-M. Dashwood, R. H. Dashwood, and E. Ho Sulforaphane Retards the Growth of Human PC-3 Xenografts and Inhibits HDAC Activity in Human Subjects Experimental Biology and Medicine, February 1, 2007; 232(2): 227 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Dashwood Frontiers in Polyphenols and Cancer Prevention J. Nutr., January 1, 2007; 137(1): 267S - 269S. [Full Text] [PDF]
|
|
|
|
|
|
R. H. Dashwood Xenobiotic Metabolism Relevance to Cancer J. Nutr., October 1, 2006; 136(10): 2681S - 2682S. [Full Text] [PDF]
|
|
|
|
|
|
C. S. Yang Dietary Factors May Modify Cancer Risk by Altering Xenobiotic Metabolism and Many Other Mechanisms J. Nutr., October 1, 2006; 136(10): 2685S - 2686S. [Full Text] [PDF]
|
|
|
|
|
|
T.-a. Matsui, Y. Sowa, T. Yoshida, H. Murata, M. Horinaka, M. Wakada, R. Nakanishi, T. Sakabe, T. Kubo, and T. Sakai Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells Carcinogenesis, September 1, 2006; 27(9): 1768 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Thomson, K. K. Brown, J. M. Pullar, and M. B. Hampton Phenethyl Isothiocyanate Triggers Apoptosis in Jurkat Cells Made Resistant by the Overexpression of Bcl-2. Cancer Res., July 1, 2006; 66(13): 6772 - 6777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Herman-Antosiewicz, D. E. Johnson, and S. V. Singh Sulforaphane Causes Autophagy to Inhibit Release of Cytochrome c and Apoptosis in Human Prostate Cancer Cells Cancer Res., June 1, 2006; 66(11): 5828 - 5835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tang, Y. Zhang, H. E. Jobson, J. Li, K. K. Stephenson, K. L. Wade, and J. W. Fahey Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract. Mol. Cancer Ther., April 1, 2006; 5(4): 935 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Myzak, K. Hardin, R. Wang, R. H. Dashwood, and E. Ho Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells Carcinogenesis, April 1, 2006; 27(4): 811 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Kim, C. Xu, Y.-S. Keum, B. Reddy, A. Conney, and A.-N. T. Kong Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with {beta}-phenylethyl isothiocyanate and curcumin Carcinogenesis, March 1, 2006; 27(3): 475 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Milner Preclinical Perspectives on Garlic and Cancer J. Nutr., March 1, 2006; 136(3): 827S - 831S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Dashwood, M. C. Myzak, and E. Ho Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis, February 1, 2006; 27(2): 344 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V Gasper, A. Al-janobi, J. A Smith, J. R Bacon, P. Fortun, C. Atherton, M. A Taylor, C. J Hawkey, D. A Barrett, and R. F Mithen Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1283 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Z. Fang, D. Chen, Y. Sun, Z. Jin, J. K. Christman, and C. S. Yang Reversal of Hypermethylation and Reactivation of p16INK4a, RAR{beta}, and MGMT Genes by Genistein and Other Isoflavones from Soy Clin. Cancer Res., October 1, 2005; 11(19): 7033 - 7041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Conaway, C.-X. Wang, B. Pittman, Y.-M. Yang, J. E. Schwartz, D. Tian, E. J. McIntee, S. S. Hecht, and F.-L. Chung Phenethyl Isothiocyanate and Sulforaphane and their N-Acetylcysteine Conjugates Inhibit Malignant Progression of Lung Adenomas Induced by Tobacco Carcinogens in A/J Mice Cancer Res., September 15, 2005; 65(18): 8548 - 8557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Singh, S. K. Srivastava, S. Choi, K. L. Lew, J. Antosiewicz, D. Xiao, Y. Zeng, S. C. Watkins, C. S. Johnson, D. L. Trump, et al. Sulforaphane-induced Cell Death in Human Prostate Cancer Cells Is Initiated by Reactive Oxygen Species J. Biol. Chem., May 20, 2005; 280(20): 19911 - 19924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-J. Yang and S. Gregoire Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication Mol. Cell. Biol., April 15, 2005; 25(8): 2873 - 2884. [Full Text] [PDF]
|
|
|
|
|
|
S. Choi and S. V. Singh Bax and Bak Are Required for Apoptosis Induction by Sulforaphane, a Cruciferous Vegetable-Derived Cancer Chemopreventive Agent Cancer Res., March 1, 2005; 65(5): 2035 - 2043. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
